Investor profile
Houman Ashrafian
Family Office & Head of Experimental Therapeutics at University of Oxford North American Office
Houman Ashrafian works as a Head of Experimental Therapeutics at University of Oxford North American Office. The firm's known portfolio counts 10 companies.
Is Houman Ashrafian a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIHardwareHealthcareSaaS
Contacts
Affiliated funds' portfolios
Head of Experimental Therapeutics at University of Oxford North American Office, whose known portfolio counts 10 companies
- OXCCU
- OrganOx
- Beacon Therapeutics
- Ultromics
- FluoRok
- Oxford Endovascular
- Wild Bioscience
- Diffblue
- Seloxium
- Bizumi
Investor Profile
Founders in the listed sectors AI, Hardware, Healthcare and SaaS, and focus areas Biotech, Computer Vision, Developer Tools and Diagnostics fall inside that listing.
Stage-wise, the deals at University of Oxford North American Office cluster around Growth, Seed and Series A rounds.
What the affiliated firm has backed is the closest available signal on whether Houman Ashrafian is worth approaching.
Colleagues at University of Oxford North American Office
Chris Morton
Royal Society Entrepreneur in Residence
London, United Kingdom
Bruno Holthof
Visiting Professor
Oxford, United Kingdom
Francesco Cesarini
Lecturer
Italy
Bastian R. Larsen
Managing Director
Copenhagen, Denmark
Jed Lye
Director
Oxford, United Kingdom
Frequently asked questions
Who is Houman Ashrafian?
Houman Ashrafian is a family office investor based in London, England, United Kingdom, listed as Head of Experimental Therapeutics at University of Oxford North American Office. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Houman Ashrafian personally.
What does Houman Ashrafian invest in?
Listed sectors include AI, Hardware, Healthcare and SaaS; listed focus areas include Biotech, Computer Vision, Developer Tools and Diagnostics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Houman Ashrafian invest at?
University of Oxford North American Office appears in Growth, Seed and Series A rounds across its known deals, and Houman Ashrafian is listed there as Head of Experimental Therapeutics. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Houman Ashrafian listed at?
Houman Ashrafian is listed as Head of Experimental Therapeutics at University of Oxford North American Office. 5 other people in the database share a firm with Houman Ashrafian.
How do I contact Houman Ashrafian?
An email address, a phone number and a LinkedIn page are on file for Houman Ashrafian. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal